scholarly journals Maternal metabolic programming of the developing central nervous system – unified pathways to metabolic and psychiatric disorders

2021 ◽  
Author(s):  
Rachel N. Lippert ◽  
Jens C. Brüning
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Psychiatric Disorders ◽  
Metabolic Programming

Neurochemical Systems in the Central Nervous System

2013 ◽  
pp. 12-26
Author(s):  
Ariel Y. Deutch ◽  
Robert H. Roth
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Psychiatric Disorders ◽  
Neurotrophic Factors ◽  
Drugs Of Abuse ◽  
Large Majority ◽  
System P ◽  
Target Neuron ◽  
The Central Nervous System ◽  
The Brain

Chapter 2 describes the neurochemical organization of the brain. It summarizes the diverse types of molecules that neurons in the brain use as neurotransmitters and neurotrophic factors, and how these molecules are synthesized and metabolized. The chapter also presents the array of receptor proteins through which these molecules regulate target neuron functioning and the reuptake proteins that generally terminate the neurotransmitter signal. Today a large majority of all drugs used to treat psychiatric disorders, as well as most drugs of abuse, still have as their initial targets proteins involved directly in neurotransmitter function.

Biological correlates of personality: considerations on the possible usefulness of central nervous system peripheral markers

1993 ◽  
Vol 8 (3) ◽  
pp. 115-124 ◽  
Author(s):  
P Castrogiovanni ◽  
F Pieraccini ◽  
I Maremmani ◽  
D Marazziti
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Psychiatric Disorders ◽  
Human Studies ◽  
Biological Research ◽  
The Central Nervous System ◽  
Methodological Problems ◽  
Biological Substrates ◽  
Peripheral Markers ◽  
Made In

SummaryAlthough a great deal of biological research has been carried out on several psychiatric disorders, it is disappointing to see how little progress has been made in the field of the biology of personality. The authors underline the methodological problems that arise in the investigation of biological substrates of human personality and review both currently available and putative peripheral markers of the central nervous system that might be used in further human studies.

Selective Unilateral Autonomic Activation: Implications for Psychiatry

CNS Spectrums ◽  
2007 ◽  
Vol 12 (8) ◽  
pp. 625-634 ◽  
Author(s):  
David S. Shannahoff-Khalsa
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Autonomic Nervous System ◽  
Psychiatric Disorders ◽  
Autonomic Nervous ◽  
Non Invasive ◽  
Autonomic Activation ◽  
Tightly Coupled ◽  
Forced Breathing ◽  
Autonomic Reflex

ABSTRACTResearch advances have led to three methods for selectively activating one half of the autonomic nervous system in humans.The first method is an ancient yogic technique called unilateral forced nostril breathing (UFNB) that employs forced breathing through only one nostril while closing off the other. The second method works by stimulation of an autonomic reflex point on the fifth intercostal space near the axilla. The most recent method employs unilateral vagus nerve stimulation (VNS) via the mid-inferior cervical branch and requires surgical implantation of a wire and pacemaker. UFNB is non-invasive and seems to selectively activate the ipsilateral branch of the sympathetic nervous system with a possible compensation effect leading to contralateral VNS. UFNB and VNS have been employed to treat psychiatric disorders. While UFNB has been studied for its potential effects on the endogenous ultradian rhythms of the autonomic and central nervous system, and their tightly coupled correlates, VNS has yet to be studied in this regard. This article reviews these three methods and discusses their similarities, putative mechanisms, their studied effects on the endogenous autonomic nervous system and central nervous system rhythms, and their implications for the treatment of psychiatric disorders.

scholarly journals Mitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders

2014 ◽  
Vol 36 (2) ◽  
pp. 156-167 ◽  
Author(s):  
Emilio L. Streck ◽  
Cinara L. Gonçalves ◽  
Camila B. Furlanetto ◽  
Giselli Scaini ◽  
Felipe Dal-Pizzol ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Psychiatric Disorders ◽  
The Central Nervous System

scholarly journals Psychiatric disorders in children with demyelinating diseases of the central nervous system

2017 ◽  
Vol 24 (9) ◽  
pp. 1243-1250 ◽  
Author(s):  
Julia Pakpoor ◽  
Raph Goldacre ◽  
Klaus Schmierer ◽  
Gavin Giovannoni ◽  
Emmanuelle Waubant ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Intellectual Disability ◽  
Psychiatric Disorders ◽  
Behavioral Disorders ◽  
Mental Health Professionals ◽  
Psychotic Disorders ◽  
Somatoform Disorders ◽  
Demyelinating Diseases ◽  
Hospital Episode

Introduction: The profile of psychiatric disorders associated with multiple sclerosis (MS) may differ in children. We aimed to assess the risk of psychiatric disorders in children with MS and other demyelinating diseases, and vice versa. Patients and methods: We analyzed linked English Hospital Episode Statistics, and mortality data, 1999–2011. Cohorts were constructed of children admitted with MS and other central nervous system (CNS) demyelinating diseases. We searched for any subsequent episode of care with psychiatric disorders in these cohorts and compared to a reference cohort. Results: Children with CNS demyelinating diseases had an increased rate of psychotic disorders (rate ratio (RR) = 5.77 (95% confidence interval (CI) = 2.48–11.41)); anxiety, stress-related, and somatoform disorders (RR = 2.38 (1.39–3.81)); intellectual disability (RR = 6.56 (3.66–10.84)); and other behavioral disorders (RR = 8.99 (5.13–14.62)). In analysis of the pediatric MS cohort as the exposure, there were elevated rates of psychotic disorders (RR = 10.76 (2.93–27.63)), mood disorders (RR = 2.57 (1.03–5.31)), and intellectual disability (RR = 6.08 (1.25–17.80)). In reverse analyses, there were elevated rates of a recorded hospital episode with CNS demyelinating disease after a previous recorded episode with anxiety, stress-related, and somatoform disorders; attention-deficit hyperactivity disorder (ADHD); autism; intellectual disability; and other behavioral disorders. Conclusion: This analysis of a national diagnostic database provides strong evidence for an association between pediatric CNS demyelinating diseases and psychiatric disorders, and highlights a need for early involvement of mental health professionals.

Immune Mechanisms Affecting the Functioning of the Central Nervous System (CNS)

2018 ◽  
pp. 47-64
Author(s):  
Moises E. Bauer ◽  
Natália P. Rocha ◽  
Wilson Savino ◽  
Antonio L. Teixeira
Keyword(s):  
Central Nervous System ◽  
T Cells ◽  
Nervous System ◽  
Psychiatric Disorders ◽  
Hippocampal Neurogenesis ◽  
Behavioral Symptoms ◽  
Immune Mechanisms ◽  
The Central Nervous System ◽  
Health And Disease ◽  
Impaired Cognition

This chapter presents an overview of the immune mechanisms affecting the functioning of the central nervous system (CNS). The cross-talk between the immune system and the CNS is established by three independent pathways: the humoral, neural, and cellular (leukocyte) routes. Of note, increased circulating pro-inflammatory cytokines and concomitant activation of brain-resident microglia can lead to impaired cognition and depressive behavioral symptoms. The activated microglia phenotype has been associated with neuroinflammation reported in neurodegenerative and psychiatric disorders. This chapter also reviews novel physiological roles for adaptive immunity (especially T cells) during health and disease. T cells support hippocampal neurogenesis, cognition, mood, resilience to stress, and are protective against the development of psychiatric disorders.

scholarly journals Social Experience-Dependent Myelination: An Implication for Psychiatric Disorders

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Michihiro Toritsuka ◽  
Manabu Makinodan ◽  
Toshifumi Kishimoto
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Psychiatric Disorders ◽  
Conduction Velocity ◽  
Neuronal Activity ◽  
Social Experience ◽  
Multiple Factors ◽  
The Central Nervous System ◽  
Extracellular Molecules ◽  
Activity Dependent

Myelination is one of the strategies to promote the conduction velocity of axons in order to adjust to evolving environment in vertebrates. It has been shown that myelin formation depends on genetic programing and experience, including multiple factors, intracellular and extracellular molecules, and neuronal activities. Recently, accumulating studies have shown that myelination in the central nervous system changes more dynamically in response to neuronal activities and experience than expected. Among experiences, social experience-dependent myelination draws attention as one of the critical pathobiologies of psychiatric disorders. In this review, we summarize the mechanisms of neuronal activity-dependent and social experience-dependent myelination and discuss the contribution of social experience-dependent myelination to the pathology of psychiatric disorders.

scholarly journals The orexins/hypocretins: hypothalamic peptides linked to sleep and appetite

2002 ◽  
Vol 32 (6) ◽  
pp. 955-958 ◽  
Author(s):  
SHAHRAD TAHERI ◽  
SEPEHR HAFIZI
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Sleep Disorder ◽  
Psychiatric Disorders ◽  
Lateral Hypothalamus ◽  
Scientific Knowledge ◽  
State Of The Art ◽  
Molecular Techniques ◽  
Medical Community ◽  
The Central Nervous System

The orexins/hypocretins are novel neuropeptides synthesized by neurons whose cell bodies are located in the lateral hypothalamus. Although these neurons are few in number, they send projections widely throughout the central nervous system (Kilduff & Peyron, 2000). There has been great excitement about the orexins/hypocretins from both the scientific and medical community. These peptides are remarkable in that they were discovered using state-of-the-art molecular techniques before their physiological actions were studied. Furthermore, there has been an exponential progress in our scientific knowledge of these peptides culminating in the orexins/hypocretins being linked to the sleep disorder, narcolepsy. With the importance of the orexins/hypocretins in sleep and arousal being increasingly recognized, it is likely that these peptides are altered by or contribute to several medical and psychiatric disorders.

scholarly journals GENOMIC INSTABILITY IN THE BRAIN: ETIOLOGY, PATHOGENESIS AND NEW BIOLOGICAL MARKERS OF PSYCHIATRIC DISORDERS

2012 ◽  
Vol 67 (9) ◽  
pp. 45-53 ◽  
Author(s):  
A. S. Tiganov ◽  
Yu. B. Yurov ◽  
S. G. Vorsanova ◽  
I.Y Yu. Yurov
Keyword(s):  
Central Nervous System ◽  
Cell Death ◽  
Nervous System ◽  
Psychiatric Disorders ◽  
Genomic Instability ◽  
Genome Analysis ◽  
Biological Marker ◽  
Molecular Medicine ◽  
Therapeutic Practice ◽  
The Brain

The latest advances in molecular medicine, medical genetics and neurobiology have provided for a new look at processes occurring in cells of the brain and have allowed to discover previously unknown phenomena associated with mental traits and to propose new biomedical direction which include genomics, psychiatry and neurobiology ― brain genomics. The application of modern molecular and cellular technologies of genome analysis in the brain in common psychiatric disorders (autism, schizophrenia and Alzheimer’s disease) has shown that genomic instability is a phathogenetic mechanism of central nervous system abnormalities and plays a role in the brain development. Genomic disbalance alters neural homeostasis leads to cell death and is an important biological marker of psychiatric disorders which determine genomic pathways. These alterations lead to synaptic disfunction and neurodegeneration. In the present review, the main advances of brain genomics and potential application in diagnostic, clinical and therapeutic practice. 

Sign in / Sign up

Export Citation Format

Share Document